华峰化学(002064) - 2024 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2024 was ¥6,628,499,796.11, a decrease of 6.11% compared to the same period last year[3]. - Net profit attributable to shareholders was ¥496,485,645.35, down 12.88% year-on-year[3]. - The net profit excluding non-recurring gains and losses was ¥453,153,393.22, a decline of 13.38% compared to the previous year[3]. - Total operating revenue for the current period reached ¥20,372,576,369.44, an increase of 3.5% compared to ¥19,681,919,713.06 in the previous period[14]. - Net profit for the current period was ¥2,019,558,231.13, representing a growth of 4.7% from ¥1,929,945,088.36 in the same period last year[15]. - The net profit attributable to shareholders of the parent company was ¥2,014,617,736.84, compared to ¥1,928,532,126.31, marking an increase of 4.5%[15]. - The comprehensive income total for the current period was ¥2,026,557,894.19, compared to ¥1,941,842,662.86, showing an increase of 4.4%[16]. Assets and Liabilities - Total assets at the end of the reporting period were ¥35,522,806,597.31, reflecting a slight increase of 0.04% from the end of the previous year[3]. - The company's cash and cash equivalents decreased to RMB 6,412,438,487.56 from RMB 10,169,442,372.18, reflecting a decline of approximately 37.3%[11]. - Accounts receivable increased to RMB 3,161,703,069.64 from RMB 2,487,730,929.16, representing a growth of about 27.1%[11]. - Inventory levels rose to RMB 4,098,015,304.13, up from RMB 3,621,177,535.45, indicating an increase of approximately 13.2%[11]. - The company's short-term borrowings increased to RMB 3,093,240,694.31 from RMB 2,645,131,092.81, marking an increase of about 16.9%[12]. - The total liabilities decreased to ¥9,226,516,759.87 from ¥10,584,392,566.06, a reduction of approximately 12.8%[13]. - Total equity attributable to shareholders of the parent company increased to ¥26,200,239,122.07 from ¥24,922,040,455.96, reflecting a growth of 5.1%[13]. Cash Flow - Operating cash inflow for the current period reached CNY 20,701,788,068.34, an increase of 13.9% compared to CNY 18,184,461,280.70 in the previous period[17]. - Net cash flow from operating activities was CNY 981,283,343.52, significantly up from CNY 440,303,176.26 in the same period last year, marking a 122.8% increase[18]. - Cash inflow from investment activities totaled CNY 4,770,210,633.63, a substantial rise from CNY 759,733,348.48 in the previous year[18]. - Cash outflow for investment activities was CNY 7,781,289,629.04, compared to CNY 2,023,236,712.87 in the previous period, indicating a 284.5% increase[18]. - Net cash flow from financing activities was CNY -2,097,487,626.28, contrasting with a positive CNY 1,848,206,021.79 in the same period last year[18]. - The total cash and cash equivalents at the end of the period decreased to CNY 5,528,280,317.03 from CNY 10,696,868,198.22, reflecting a decline of 48.3%[18]. Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 62,744[7]. - Shareholders' equity attributable to the parent company increased by 5.13% to ¥26,200,239,122.07 compared to the end of the previous year[3]. Other Financial Metrics - Research and development expenses for the current period were ¥721,240,163.35, slightly down from ¥750,762,807.62, indicating a decrease of 3.9%[15]. - Basic earnings per share rose to ¥0.41 from ¥0.39, an increase of 5.1%[16]. - The company reported a decrease in tax expenses to ¥267,702,640.24 from ¥200,582,387.29, reflecting a year-over-year increase of 33.4%[15]. - The company recorded a 64.87% increase in other income to ¥201,802,368.13, attributed to increased VAT deductions[6]. - The company experienced a 101.39% increase in asset impairment losses, totaling -¥2,581,801.12, mainly due to increased inventory write-downs[6]. - The company has not undergone an audit for the third quarter report[19].